rs17070905

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182920.2(ADAMTS9):​c.5798G>A​(p.Arg1933Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00793 in 1,613,902 control chromosomes in the GnomAD database, including 485 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 56 hom., cov: 33)
Exomes 𝑓: 0.0077 ( 429 hom. )

Consequence

ADAMTS9
NM_182920.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.558

Publications

13 publications found
Variant links:
Genes affected
ADAMTS9 (HGNC:13202): (ADAM metallopeptidase with thrombospondin type 1 motif 9) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
ADAMTS9 Gene-Disease associations (from GenCC):
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • ciliopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020031333).
BP6
Variant 3-64522181-C-T is Benign according to our data. Variant chr3-64522181-C-T is described in ClinVar as Benign. ClinVar VariationId is 1294798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0615 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS9NM_182920.2 linkc.5798G>A p.Arg1933Gln missense_variant Exon 39 of 40 ENST00000498707.5 NP_891550.1 Q9P2N4-3
ADAMTS9NM_001318781.2 linkc.5714G>A p.Arg1905Gln missense_variant Exon 38 of 39 NP_001305710.1 Q9P2N4-4
ADAMTS9XR_007095711.1 linkn.6057G>A non_coding_transcript_exon_variant Exon 38 of 40
ADAMTS9XR_245151.1 linkn.6141G>A non_coding_transcript_exon_variant Exon 39 of 41

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS9ENST00000498707.5 linkc.5798G>A p.Arg1933Gln missense_variant Exon 39 of 40 1 NM_182920.2 ENSP00000418735.1 Q9P2N4-3

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1530
AN:
152210
Hom.:
53
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00251
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0488
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.0670
Gnomad SAS
AF:
0.0360
Gnomad FIN
AF:
0.00555
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.0143
GnomAD2 exomes
AF:
0.0226
AC:
5667
AN:
251268
AF XY:
0.0202
show subpopulations
Gnomad AFR exome
AF:
0.00178
Gnomad AMR exome
AF:
0.0964
Gnomad ASJ exome
AF:
0.00288
Gnomad EAS exome
AF:
0.0614
Gnomad FIN exome
AF:
0.00397
Gnomad NFE exome
AF:
0.00109
Gnomad OTH exome
AF:
0.0137
GnomAD4 exome
AF:
0.00770
AC:
11258
AN:
1461574
Hom.:
429
Cov.:
30
AF XY:
0.00799
AC XY:
5809
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33454
American (AMR)
AF:
0.0933
AC:
4167
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.00279
AC:
73
AN:
26128
East Asian (EAS)
AF:
0.0750
AC:
2978
AN:
39688
South Asian (SAS)
AF:
0.0291
AC:
2510
AN:
86246
European-Finnish (FIN)
AF:
0.00350
AC:
187
AN:
53408
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5764
European-Non Finnish (NFE)
AF:
0.000681
AC:
757
AN:
1111820
Other (OTH)
AF:
0.00864
AC:
522
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
541
1081
1622
2162
2703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1543
AN:
152328
Hom.:
56
Cov.:
33
AF XY:
0.0120
AC XY:
892
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00250
AC:
104
AN:
41582
American (AMR)
AF:
0.0495
AC:
757
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.0673
AC:
348
AN:
5170
South Asian (SAS)
AF:
0.0365
AC:
176
AN:
4828
European-Finnish (FIN)
AF:
0.00555
AC:
59
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000838
AC:
57
AN:
68024
Other (OTH)
AF:
0.0137
AC:
29
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
70
140
210
280
350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00719
Hom.:
105
Bravo
AF:
0.0142
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.0194
AC:
2360
Asia WGS
AF:
0.0510
AC:
176
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.00113

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ADAMTS9-related disorder Benign:1
Jun 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
15
DANN
Benign
0.44
DEOGEN2
Benign
0.037
T;.
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0020
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-1.3
N;.
PhyloP100
0.56
PrimateAI
Benign
0.26
T
PROVEAN
Benign
1.8
N;N
REVEL
Benign
0.046
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.042
MPC
0.22
ClinPred
0.014
T
GERP RS
0.86
Varity_R
0.054
gMVP
0.17
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17070905; hg19: chr3-64507857; COSMIC: COSV55777338; API